ライフサイエンスコーパス: ill

1 onavirus 2 (SARS-CoV-2) or becoming severely ill.

2 kidney recipients, and 25.0% were critically ill.

3 cardiac surgery, and 692 who were critically ill.

4 sociated with poor outcome in the critically ill.

5 However, not all will fall ill.

6 rgency department boarding of the critically ill.

7 o inform delirium research in the critically ill.

8 associated with prognosis in the critically ill.

9 slation of directives of the neurocritically ill.

10 COVID-19, of which 257 (22%) were critically ill.

11 action of patients as they became critically ill.

12 eonatal, pediatric, trauma, or noncritically ill.

13 ell as those where healthcare workers became ill.

14 ncy department boarding among the critically ill, (2) the outcomes associated with critical care pati

15 However, these enzymes are ill-adapted to industrial processes and suffer from low

16 ment modalities, and mortality in critically ill adult hemophagocytic lymphohistiocytosis patients.

17 Critically ill adult mechanically ventilated coronavirus disease 20

18 through April 2014, we recruited critically ill adult patients (>=18 years) with severe AKI in two U

19 y common clinical intervention in critically ill adult patients.

20 duction in acute kidney injury in critically ill adults (odds ratio, 0.47; 95% CI, 0.34-0.65) and a 2

21 multicenter randomized trials of critically ill adults in which mortality was the main endpoint.

22 ts (ICUs), we enrolled conscious, critically ill adults who had a tracheostomy tube; patients were el

23 Four critically ill adults with coronavirus disease 19 pneumonia that fa

24 : guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19).

25 rtality rates exceeding 50% among critically ill adults with coronavirus disease 2019, particularly a

26 multicenter cohort study of 3099 critically ill adults with COVID-19 admitted to intensive care unit

27 nasal cannula after extubation in critically ill adults.

28 cian colleagues to care for these critically ill adults.

29 trategy on acute kidney injury in critically ill adults.

30 considerations in caring for the critically ill and facilitates patient-centered, evidence-based, an

31 sociated microbial communities in critically ill and healthy infants, facilitated by NanoOK RT softwa

32 r presentation, patients being less severely ill and receiving treatment sooner.

33 Most patients (74%; 37/50) were critically ill and treated on intensive care unit.

34 admissions, are more chronically and acutely ill, and more frequently have sepsis than those admitted

35 oroquine-treated patients were more severely ill at baseline than those who did not receive hydroxych

36 e >= 14 years, on ART >6 months, not acutely ill, CD4 count not <200 cells/mm3) and willingness to pa

37 prevalence of rehabilitation for critically ill children and associated barriers.

38 Critically ill children are frequently exposed to noninvasive venti

39 ficult bag-mask ventilation among critically ill children are not well studied.

40 abilitation interventions for all critically ill children at risk of functional impairments.

41 est clinical risk and to identify critically ill children in whom malaria is not the primary cause.

42 In acutely ill children receiving rWGS for diagnosis of genetic dis

43 s, and predictors of mortality in critically ill children with ADHF.

44 In critically ill children, NMR metabolomics differentiates well betwe

45 that in a heterogeneous group of critically ill children, there would be different metabolic profile

46 Delirium occurs frequently in critically ill children, with highest rates reported in children un

47 e acquired in plasma samples from critically ill children.

48 toring device for hemodynamics in critically ill children.

49 aureus in previously healthy and chronically ill children.

50 d to avoid tracheal intubation in critically ill children.

51 ated with short-term mortality in critically ill cirrhotic patients.

52 Overall mortality to date in this critically ill cohort is 30.9% (67/217) and 60.4% (131/217) patient

53 were similar in the surgical and critically ill cohorts.

54 Ill-conceived policies have the potential to cause sever

55 many decades and is worsened by a number of ill-conceived strategies and policies.

56 actor with coupled models and up to 100 with ill-conditioned models along with a 14-fold decrease in

57 stics, treatment, and outcomes of critically ill coronavirus disease 2019 (COVID-19) solid organ tran

58 One-hundred nine critically ill coronavirus disease 2019 patients admitted to the IC

59 ency of venous thromboembolism in critically ill coronavirus disease 2019 patients and associate a de

60 ng current and projected needs of critically ill coronavirus disease 2019 patients.

61 nd a high incidence of CAPA among critically ill COVID-19 patients and that its occurrence seems to c

62 Critically ill COVID-19 patients, but not those with mild symptoms,

63 To overcome the surge of critically ill COVID-19 patients, reallocating health care workers

64 and cryptococcal meningitis coinfection are ill defined.

65 sensitization and disease development remain ill defined.

66 2 and related coronavirus life cycles remain ill defined.

67 the hepatic benefits of metformin are still ill defined.

68 person-to-person transmission have remained ill defined.

69 nagement of pregnancy-associated TMA remains ill defined.

70 factors responsible for that control remain ill defined.

71 However, the mechanisms involved remain ill-defined and even controversial.

72 tion between the presence of calcifications, ill-defined borders and overall observer suspicion or im

73 The presence of calcifications, ill-defined borders and the overall impression or suspic

74 ection of cells in challenging datasets with ill-defined cell boundaries.

75 ptic proteins are associated with a group of ill-defined central nervous system (CNS) autoimmune dise

76 However, there currently are ill-defined diagnostic classification issues among LATE-

77 On palpation, few ill-defined firm mobile masses were found in the upper o

78 es that work well in silicon technology have ill-defined interfaces with 2D materials and numerous de

79 Self-discrimination, a critical but ill-defined molecular process programmed during thymocyt

80 dyes has been studied in diverse media, the ill-defined nature of these aggregates has made it diffi

81 , and provided mechanistic insights into the ill-defined placental lipotoxicity that may inspire PLA2

82 Fibroblasts are an ill-defined population consisting of highly proliferativ

83 teristic of inorganic semiconductors and the ill-defined relative energetics between semiconductors a

84 Computed tomography (CT) noted ill-defined soft tissue thickening anterior to the right

85 Although the underlying mechanisms are ill-defined, the differentiation and maturation of cross

86 strain diversity in small ruminants remains ill-defined, thus limiting the accuracy of BSE surveilla

87 nature and extent of phosphorylation remain ill-defined.

88 presentations, but the latter remains rather ill-defined.

89 herapy and role of radiotherapy (RT) remains ill-defined.

90 the underlying role of mitochondria remains ill-defined.

91 which render a patient LC amyloidogenic are ill-defined.

92 logical functions of each bromodomain remain ill-defined.

93 ity, but their role in severe asthma remains ill-defined.

94 -like ligands in disc growth control remains ill-defined.

95 various glycosaminoglycan substrates remain ill-defined.

96 ne the cell repertoire for each organ remain ill-defined.

97 evalence in persons who inject drugs remains ill-defined.

98 progenitor states and lineage choice remain ill-defined.

99 communicate with patients who are seriously ill from COVID-19 infection.

100 ants dying from EEHV1 hemorrhagic disease or ill from EEHV infection were seronegative for the EEHV s

101 at this behaviour confers protection against ill health [3] is supported by the description of anti-p

102 s, both risk factors for mental and physical ill health.

103 s raise concerns regarding society's mental (ill)health and the prevalence of insufficient and disrup

104 1 mortality (4.8%) to date, in a critically ill heart/kidney patient who had been in the ICU before

105 vestigating treatment tailored to critically ill hemophagocytic lymphohistiocytosis patients are high

106 -negative HABP/VABP, including in critically ill, high-risk patients.

107 parison to the mortality of other critically ill ICU patients classified into six other diagnostic su

108 l pathogen that primarily infects critically ill individuals.

109 ative and quantitative CC size in critically ill infants following surgical and critical care for lon

110 Gravely ill infants were not randomized and received ultra-rapid

111 In a cohort of acutely ill Kenyan children, prescription of antimalarial therap

112 these infections when the patient is acutely ill leads to excess morbidity and mortality.

113 circulating microRNA expression in severely ill ME/CFS patients before and after an innovative stres

114 ngal disease occurs frequently in critically ill, mechanically ventilated COVID-19 patients.

115 In critically ill, mechanically ventilated patients, daily interruptio

116 commends chemoprophylaxis for non-critically ill medical inpatients, leaving much to the discretion o

117 icantly increasing major bleeding in acutely ill medical patients after discharge.

118 Hospitalized acutely ill medical patients are at risk for fatal and major thr

119 a1a) therapy was commonly used in critically ill MERS patients but was not associated with reduction

120 the public health investigation of a mildly ill, nonhospitalized COVID-19 case who traveled to China

121 Across 11 studies, compared with critically ill nonseptic, septic patients had significantly increas

122 g the decision to offer surgery to seriously ill older adults and surgeons' moral distress.

123 Survival in critically ill oncology and hematology patients with sepsis improve

124 ogical techniques if infants were critically ill or a structural magnetic resonance imaging of the br

125 Severely ill or mentally disabled patients who were not able to f

126 department-based boarding of the critically ill patient is common, but no nationally representative

127 way skills involved in managing a critically ill patient.

128 n to the respiratory drive of the critically ill patient.

129 rticles pertained to transport of critically ill patients (4%).

130 ld-to-moderate patients to 88% in critically ill patients (p=0.036).

131 severity by Glasgow Coma Scale in critically ill patients (rho, -0.54; p = 0.036).

132 predicts in-hospital mortality in critically ill patients across the glycemic spectrum.

133 m from 321 prospectively enrolled critically ill patients and compared with clinical outcomes.

134 ther important considerations for critically ill patients and evaluated interventions to reduce the r

135 complement pathway in a series of critically ill patients and in a mouse pneumonia model.Methods: Tot

136 terations of circadian rhythms in critically ill patients and to evaluate associations between brain

137 ral database of perioperative and critically ill patients and to use this automatic algorithm to data

138 translation of directives in neurocritically ill patients are increasing.

139 determine if clinical outcomes of critically ill patients are predicted by features of the lung micro

140 gainst indirect calorimetry among critically ill patients at different phases of critical illness.

141 that improve clinical outcomes of critically ill patients boarded in the emergency department.

142 More notably, critically ill patients displayed hallmarks of extrafollicular B ce

143 Rehabilitation interventions in critically ill patients do not influence mortality and are safe.

144 Critically ill patients for whom the physician decided to test prel

145 ies describing directives of neurocritically ill patients from 2000 to 2019.

146 Recent research in critically ill patients has highlighted other important considerati

147 ty trial designs and exclusion of critically ill patients in many trials.

148 c pathogen that primarily infects critically ill patients in nosocomial settings.

149 sible role in the routine care of critically ill patients in the future.

150 be used in the future to stratify critically ill patients in the ICU according to their immune status

151 of ketamine discussed focused on critically ill patients in the ICU and emergency department setting

152 identifying the immune profile of critically ill patients in the intensive care unit (ICU).

153 ID-19 and the large population of critically ill patients included in these analyses, the mortality r

154 several disease states impacting critically ill patients including pain, alcohol withdrawal syndrome

155 wing that anxiety at admission in critically ill patients is associated with new organ failure over t

156 ntibody testing in identification of acutely ill patients or in epidemiological settings.

157 Critically ill patients rapidly enter a state of behavioral quiesce

158 ence of venous thromboembolism in critically ill patients receiving different regimens of prophylacti

159 Its incidence and outcome in critically ill patients remain, however, largely unknown.

160 notropic and vasopressor agent in critically ill patients requiring hemodynamic support.

161 ration rivaroxaban in hospitalized medically ill patients resulted in a 28% reduction in fatal and ma

162 Almost 10% of these critically ill patients subsequently die.

163 ence of venous thromboembolism in critically ill patients supported by venovenous extracorporeal memb

164 ignature was higher in individual critically ill patients than healthy patients (4.90 vs 1.48 hr) and

165 nical characteristics of infected critically ill patients that mediate the associated pathogenesis, i

166 om the morbidity and mortality of critically ill patients to the diagnosis and prognosis of acute isc

167 n injury are less well studied in critically ill patients treated with continuous kidney replacement

168 Emergency department boarding of critically ill patients was common and was associated with worse cl

169 Mortality among these critically ill patients was high.

170 hours and conventional therapy in critically ill patients were included.

171 nts and Main Results: Lungs of 91 critically ill patients were sampled using miniature BAL within 24

172 Medically ill patients with a baseline creatinine clearance >=50 m

173 Among critically ill patients with acute kidney injury receiving continuo

174 infective complication affecting critically ill patients with acute respiratory distress syndrome fo

175 es a mixed fibrinolytic phenotype in acutely ill patients with cirrhosis with baseline hypofibrinolys

176 and its relationship with outcome in acutely ill patients with cirrhosis.

177 s factor alpha, IL-6, and IL-8 in critically ill patients with coronavirus disease 2019 (COVID-19) vs

178 drome, mesenteric ischemia) among critically ill patients with coronavirus disease 2019 (COVID-19)- v

179 A large proportion of critically ill patients with coronavirus disease 2019 have hypercoa

180 re, and could improve survival in critically ill patients with coronavirus disease 2019 infection.

181 ed thromboelastography studies in critically ill patients with coronavirus disease 2019 to characteri

182 In this cohort of critically ill patients with coronavirus disease 2019, neither time

183 milieu in the lungs and blood of critically ill patients with COVID-19 acute respiratory distress sy

184 In this study of critically ill patients with COVID-19 and acute respiratory failure

185 AKI-RRT is common among critically ill patients with COVID-19 and is associated with a hosp

186 e-wide association study in 2,244 critically ill patients with COVID-19 from 208 UK intensive care un

187 unit (ICU) stay suggest that many critically ill patients with COVID-19 will face long-lasting physic

188 port brain imaging features in 11 critically ill patients with COVID-19 with persistently diminished

189 e similar between SOT and non-SOT critically ill patients with COVID-19.

190 cocorticoid, enhanced survival of critically ill patients with COVID-19.

191 gh risk of complications; half of critically ill patients with difficult airways experience life-thre

192 h diseases of other major organs, critically ill patients with ESKD were not more likely to have a DN

193 ive, observational study included critically ill patients with influenza associated with pulmonary as

194 In this case series of critically ill patients with laboratory-confirmed COVID-19 admitted

195 s a retrospective cohort study of critically ill patients with laboratory-confirmed MERS from 14 hosp

196 Mortality of severely ill patients with liver disease in district general hosp

197 /rIFN) therapy on the outcomes of critically ill patients with Middle East respiratory syndrome (MERS

198 allenging problems in the care of critically ill patients with oliguric acute kidney injury.

199 Critically ill patients with sepsis or septic shock are at an incre

200 entially biomarker information in critically ill patients with sepsis.

201 cision medicine to the bedside of critically ill patients with sepsis.

202 ctive Corticosteroid Treatment in Critically Ill Patients with Septic Shock and Activated Protein C a

203 ctive Corticosteroid Treatment in Critically Ill Patients with Septic Shock and Activated Protein C a

204 ctive Corticosteroid Treatment in Critically Ill Patients with Septic Shock and hydrocortisone at a 5

205 ctive Corticosteroid Treatment in Critically Ill Patients with Septic Shock) and $30,911 (Activated P

206 ctive Corticosteroid Treatment in Critically Ill Patients with Septic Shock, adjunctive hydrocortison

207 al was terminated early after 596 critically ill patients with severe acute kidney injury or clinical

208 during vasopressor support among critically ill patients with shock and to determine whether such re

209 rse kidney-related outcomes among critically ill patients with shock.Objectives: To investigate the m

210 end-expiratory pressure (PEEP) in critically ill patients without acute respiratory distress syndrome

211 Compared with critically ill patients without major organ disease, patients with

212 injury from the infection (22% of critically ill patients).

213 Registry in ICUs) enrolled 2,087 critically ill patients, and AdrenOSS-1 (Adrenomedullin and Outcome

214 , very specific subpopulations of critically ill patients, and on early goal-directed therapy.

215 us catheters, are often needed in critically ill patients, but also are associated with complications

216 ring for the anticipated surge in critically ill patients, but few are wholly equipped to manage this

217 tive in enhancing the recovery of critically ill patients, but more large-scale, multicenter randomiz

218 jury (ALI), a common condition in critically ill patients, has limited treatments and high mortality.

219 We studied 112 critically ill patients, including 53 with sepsis and 59 with intra

220 We studied 112 critically ill patients, including 53 with sepsis and 59 with intra

221 emergency department boarding of critically ill patients, including emergency department-based inter

222 nts with ESKD compared with other critically ill patients, including those with diseases of other maj

223 ccurrence of new organ failure in critically ill patients, independently of respiratory status and se

224 nt studies have revealed that, in critically ill patients, lung microbiota are altered and correlate

225 Among 217 critically ill patients, mortality for those who required mechanica

226 nity-based sample of recovered and currently ill patients, similar to reports from a number of studie

227 ous kidney replacement therapy in critically ill patients, the evidence for this recommendation is ba

228 16 years old), pregnant women, noncritically ill patients, very specific subpopulations of critically

229 In critically ill patients, we showed that mitophagy was inhibited in

230 ia and hemodynamic instability in critically ill patients.

231 f the central circadian rhythm in critically ill patients.

232 related with improved outcome for critically ill patients.

233 ted bacteria) predict outcomes in critically ill patients.

234 rine administration on outcome of critically ill patients.

235 erritinemia is frequently seen in critically ill patients.

236 e unit, with a proven benefit for critically ill patients.

237 hysiology of respiratory drive in critically ill patients.

238 itution prepared for an influx of critically ill patients.

239 longed endotracheal intubation in critically ill patients.

240 as a predictor of outcomes among critically ill patients.

241 n injury and improved outcomes in critically ill patients.

242 rt and of short-term mortality in critically ill patients.

243 ry distress syndrome is common in critically ill patients.

244 ome compared with normothermia in critically ill patients.

245 avage and cerebrospinal fluids of critically ill patients.

246 ibility of acute kidney injury in critically ill patients.

247 ibility of acute kidney injury in critically ill patients.

248 heir impact on the outcome of non-critically ill patients.

249 ssociated with a worse outcome in critically ill patients.

250 ted with increase risk of harm in critically ill patients.

251 paired intestinal transit even in critically ill patients.

252 mproving the delivery of care for critically ill patients.

253 tubation is commonly performed in critically ill patients.

254 utive endotracheal intubations in critically ill patients.

255 the donor pool in this subset of critically ill patients.

256 a cohort of septic and nonseptic critically ill patients.

257 e point of care, particularly for critically ill patients.

258 ot used to track contractility in critically ill patients.

259 occlusion pressure in ventilated critically ill patients.

260 uired for mechanically ventilated critically ill patients.

261 ion to the intensive care unit in critically ill patients.

262 sessing thromboembolic disease in critically ill patients.

263 n extubation failure detection in critically ill patients.

264 in significant fluid overload in critically ill patients.

265 both common and consequential in critically ill patients.

266 eatures more commonly observed in critically ill patients.(C) RSNA, 2020.

267 tals using an inception cohort of critically ill patients.Measurements and Main Results: Using the Ph

268 be a lifesaving intervention for critically ill patients; however, mortality remains high.

269 conducted on peripheral blood obtained from ill pediatric patients (age 1 day to 18 years).

270 Descriptive feasibility study of critically ill pediatric patients with suspected monogenic conditio

271 of ultra-rapid genomic testing in critically ill pediatric patients with suspected monogenic conditio

272 ed nanosystem toward rapid identification of ill people even at incubation and prodromal periods of i

273 l membrane oxygenation to support critically ill, poisoned patients in the United States is increasin

274 The cohort represented an ill population with 69% in the intensive care unit, 63%

275 us descriptions of endotypes in a critically ill population with acute respiratory distress syndrome

276 ss disorder were similar to other critically ill populations and were related to physical disability

277 correction of prebleaching is known to be an ill-posed problem, limiting the utility of the technique

278 e prediction problems are usually considered ill-posed, as the amount of samples is very limited with

279 opted electronic health records, they may be ill prepared to adopt machine learning and artificial in

280 n countries with moderate risk that might be ill-prepared to detect imported cases and to limit onwar

281 munities and faecal samples from healthy and ill preterm infants.

282 l-admitted COVID-19 patients (144 critically ill) primarily receiving standard-dose prophylactic anti

283 In the critically ill, radiographically confirmed VTE and major bleeding r

284 d hospital controls, costs of the critically ill remained higher throughout the follow-up.

285 ide such campaigns, human behaviour is often ill-represented, if at all.

286 of graft failure in individual cases remain ill studied.

287 A more severely ill subgroup, Improving Pediatric Sepsis Outcomes Critic

288 Current multivariate approaches to GWAS are ill-suited for complex, large-scale data of this kind.

289 d that available bioinformatics tools may be ill-suited for verification and highlight the importance

290 normally required of university leaders were ill-suited to mounting an emergency response.

291 Critically ill surgical patients may receive concomitant aspirin an

292 ial to measure high quality PC for seriously ill surgical patients throughout the surgical episode.

293 nt aspirin and anticoagulation in critically ill surgical patients was associated with an increased r

294 Among critically ill surgical sepsis patients, persistent AKI and the abs

295 and respiratory samples from 719 critically ill UK patients with COVID-19 and suspected pulmonary as

296 these models have hardly been linked to the ill-understood neurobiological changes that occur in the

297 ome segregation; yet how this occurs remains ill-understood.

298 atory-confirmed COVID-19 and were critically ill with acute hypoxaemic respiratory failure, and colle

299 py for existing conditions prior to becoming ill with COVID-19 have different outcomes from patients

300 many levels of care for patients critically ill with COVID-19.